COVID-19: MEPs discuss ways to increase roll-out of vaccines with pharma CEOs
In a hearing yesterday, MEPs demanded clarity on vaccine deliveries and insisted that pharmaceutical companies honour their contracts.
MEPs quizzed CEOs and representatives of leading pharmaceutical companies, including AstraZeneca, Moderna, CureVac, Novavax, Pfizer and Sanofi, on how to remove obstacles to faster commercialisation, manufacturing and distribution of vaccines.
You can watch a recording of the hearing here.
During the discussion, MEPs asked about global technology transfers, sharing patents, and how industry intends to update the vaccines in order to keep up with emerging variants. They also grilled CEOs on how the European Medicines Agency could speed up market approval at European level. Some MEPs asked whether an EU export ban on vaccines would help Europe compared to other countries that have introduced export bans. In their remarks, industry representatives highlighted the challenge of building production capacity for entirely new and complex products, and the international nature of supply chains.
“This was a world first: CEOs of the main vaccine manufacturers appearing before elected representatives. It’s good for transparency, and it’s good for democracy. It is crucial to regularly check accountability and commitments made. Moreover, the race to produce vaccines is intensifying and we are gearing up to use all available tools to support it. This was the point of this hearing”, said Environment, Public Health and Food Safety Chairman Pascal Canfin (Renew Europe, FR) yesterday. “The European Parliament will play its role fully to win the vaccine deployment battle. The contact group put in place by the Parliament and Commission will further strengthen our role”, he added.
“Today’s challenge is about how to produce extremely complex products on a scale that is absolutely unprecedented. This is an industrial challenge”, said Industry, Research and Energy Committee Chairman Cristian Bușoi (EPP, RO) yesterday. “This hearing was an exercise in democratic accountability. We wanted to know where the production bottlenecks are and to have a clear picture about the industry’s commitments and obligations. But we also want to help the industry deliver the doses, because our priority is to get vaccination done”.
Latest News from
Presentation by Commissioner Hahn of the NextGenerationEU – Funding strategy to finance the Recovery Plan for Europe16/04/2021 15:20:00
Presentation given recently (14 April 2021) by Commissioner Hahn of the NextGenerationEU – Funding strategy to finance the Recovery Plan for Europe.
COVID-19: Council agrees its negotiating mandate on the Digital Green Certificate16/04/2021 14:05:00
EU ambassadors recently (14 April 2021) agreed a mandate for negotiations with the European Parliament on the proposal for a Digital Green Certificate.
Statement by President von der Leyen on developments in the Vaccines Strategy16/04/2021 13:15:00
Statement given recently (14 April 2021) by President von der Leyen on developments in the Vaccines Strategy.
"The state of the world order and the importance of the India-EU relationship" - Address by President Charles Michel at the Raisina Dialogue 202116/04/2021 11:05:00
Address given recently (14 April 2021) by President Charles Michel at the Raisina Dialogue 2021.
Retail Clients Continue to Lose Out Due to High Investment Products Costs15/04/2021 14:10:00
The European Securities and Markets Authority (ESMA), the EU securities regulator, yesterday published its third annual statistical report on the cost and performance of European Union (EU) retail investment products.
ESMA Publishes Annual Peer Review of EU CCP Supervision09/04/2021 11:10:00
The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, yesterday published its annual peer review report on the supervision of EU Central Counterparties (CCPs) by National Competent Authorities (NCAs).
ESMA Report Highlights Liquidity Concerns For Alternative Investment Funds08/04/2021 15:20:00
The European Securities and Markets Authority (ESMA), the EU securities regulator, today publishes its third annual statistical report on the Alternative Investment Fund (AIF) sector.
ESMA Publishes Draft Regulatory Technical Standards on Changes to CCPS’ Activities And Models08/04/2021 13:25:00
The European Securities and Markets Authority, the EU’s securities markets regulator, today published its Final Report containing draft regulatory technical standards (RTS) relating to changes to central counterparty (CCP) services and activities, as well as models and parameters under the European Markets Infrastructure Regulation (EMIR).
Joint Statement by Commissioner Reynders and Yoon Jong In, Chairperson of the Personal Information Protection Commission of the Republic of Korea30/03/2021 15:25:00
In their call today, Commissioner for Justice Didier Reynders and Chairperson of the Personal Information Protection Commission Yoon Jong In welcomed the successful conclusion of the adequacy talks between the European Union and the Republic of Korea.